Meruelo, Daniel
- Cynvec, LLC (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
FY2022 NIH rank #11,641
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2022
Linked Award Amount
$866.7K
Full award amounts, FY2022
Award Records
1
Records listing this PI
Award-Linked Rank
#11,641
By linked amount among FY2022 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2022 award records by amount
NIH award records listing Meruelo, Daniel as a PI. Multi-PI records show the full award amount for context.
- 5R44CA250627-03R44Contact PIA novel and effective immunotherapeutic approach for tumors with a low mutational load and few tumor-infiltrating lymphocytes, such as ovarian cancer$866.7Kaward amount
Award organization
Organizations that administered FY2022 awards listing Meruelo, Daniel as a PI.
FY2022 award administered by Cynvec, LLC ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardCynvec, LLC
- 2001$500K Cumulative Funding
- 2001Entered Top 50% NationallyRanked #7009
- 2002$1M Cumulative Funding
- 2004$2M Cumulative Funding
- 2021$5M Cumulative Funding